BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34668635)

  • 1. Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repair.
    Walton K; Walker K; Riddle M; Koehn BH; Reff J; Sagatys EM; Linden MA; Pidala J; Kim J; Lee MC; Kiluk JV; Hui JYC; Yun SY; Xing Y; Stefanski H; Lawrence HR; Lawrence NJ; Tolar J; Anasetti C; Blazar BR; Sebti SM; Betts BC
    Am J Transplant; 2022 Mar; 22(3):717-730. PubMed ID: 34668635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining Treg and antitumor CTL function.
    Betts BC; Veerapathran A; Pidala J; Yang H; Horna P; Walton K; Cubitt CL; Gunawan S; Lawrence HR; Lawrence NJ; Sebti SM; Anasetti C
    Sci Transl Med; 2017 Jan; 9(372):. PubMed ID: 28077684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Aurora A and JAK2 kinase blockade effectively suppresses malignant transformation.
    Yang H; Lawrence HR; Kazi A; Gevariya H; Patel R; Luo Y; Rix U; Schonbrunn E; Lawrence NJ; Sebti SM
    Oncotarget; 2014 May; 5(10):2947-61. PubMed ID: 24930769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results.
    Pidala J; Walton K; Elmariah H; Kim J; Mishra A; Bejanyan N; Nishihori T; Khimani F; Perez L; Faramand RG; Davila ML; Nieder ML; Sagatys EM; Holtan SG; Lawrence NJ; Lawrence HR; Blazar BR; Anasetti C; Sebti SM; Betts BC
    Clin Cancer Res; 2021 May; 27(10):2712-2722. PubMed ID: 33753457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation.
    Betts BC; Bastian D; Iamsawat S; Nguyen H; Heinrichs JL; Wu Y; Daenthanasanmak A; Veerapathran A; O'Mahony A; Walton K; Reff J; Horna P; Sagatys EM; Lee MC; Singer J; Chang YJ; Liu C; Pidala J; Anasetti C; Yu XZ
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1582-1587. PubMed ID: 29382747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigen.
    Betts BC; Abdel-Wahab O; Curran SA; St Angelo ET; Koppikar P; Heller G; Levine RL; Young JW
    Blood; 2011 Nov; 118(19):5330-9. PubMed ID: 21917753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect.
    Choi J; Cooper ML; Alahmari B; Ritchey J; Collins L; Holt M; DiPersio JF
    PLoS One; 2014; 9(10):e109799. PubMed ID: 25289677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen Stimulation History Impacts Donor-Specific CD8(+) T Cell Susceptibility to Costimulation/Integrin Blockade-Based Therapy.
    Badell IR; Kitchens WH; Wagener ME; Lukacher AE; Larsen CP; Ford ML
    Am J Transplant; 2015 Dec; 15(12):3081-94. PubMed ID: 26228897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary lymphoid tissue and costimulation-blockade resistant rejection: A nonhuman primate renal transplant study.
    Mulvihill MS; Samy KP; Gao QA; Schmitz R; Davis RP; Ezekian B; Leopardi F; Song M; How T; Williams K; Barbas A; Collins B; Kirk AD
    Am J Transplant; 2019 Aug; 19(8):2350-2357. PubMed ID: 30891931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545.
    Deuse T; Hua X; Taylor V; Stubbendorff M; Baluom M; Chen Y; Park G; Velden J; Streichert T; Reichenspurner H; Robbins RC; Schrepfer S
    Transplantation; 2012 Oct; 94(7):695-702. PubMed ID: 22971540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trichinella spiralis infection changes immune response in mice performed abdominal heterotopic cardiac transplantation and prolongs cardiac allograft survival time.
    Deng G; Deng R; Yao J; Liao B; Chen Y; Wu Z; Hu H; Zhou X; Ma Y
    Parasitol Res; 2016 Jan; 115(1):407-14. PubMed ID: 26481486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.
    Thornley TB; Brehm MA; Markees TG; Shultz LD; Mordes JP; Welsh RM; Rossini AA; Greiner DL
    J Immunol; 2006 Feb; 176(3):1561-70. PubMed ID: 16424185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of MyD88 signaling induces donor-specific kidney allograft tolerance.
    Wu H; Noordmans GA; O'Brien MR; Ma J; Zhao CY; Zhang GY; Kwan TK; Alexander SI; Chadban SJ
    J Am Soc Nephrol; 2012 Oct; 23(10):1701-16. PubMed ID: 22878960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase Cθ controls type 2 innate lymphoid cell and T
    Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
    J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantation.
    Wood S; Feng J; Chung J; Radojcic V; Sandy-Sloat AR; Friedman A; Shelton A; Yan M; Siebel CW; Bishop DK; Maillard I
    J Immunol; 2015 Mar; 194(6):2899-908. PubMed ID: 25687759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional modulation of the T helper 17/interleukin 17 axis ameliorates renal ischemia-reperfusion injury.
    Lee JW; Bae E; Kwon SH; Yu MY; Cha RH; Lee H; Kim DK; Lee JP; Ye SK; Yoo JY; Park DJ; Kim YS; Yang SH
    Nephrol Dial Transplant; 2019 Sep; 34(9):1481-1498. PubMed ID: 30544214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of miR-673-5p expression in the cornea promotes rat corneal allograft rejection by promoting Th17 cell differentiation mediated by JAK2/STAT3.
    Cao Q; Li Y; Li Y; Li L
    Ann Transl Med; 2021 Sep; 9(18):1409. PubMed ID: 34733961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 producing type 2 innate lymphoid cells prolong islet allograft survival.
    Huang Q; Ma X; Wang Y; Niu Z; Wang R; Yang F; Wu M; Liang G; Rong P; Wang H; Harris DC; Wang W; Cao Q
    EMBO Mol Med; 2020 Nov; 12(11):e12305. PubMed ID: 33034128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice.
    Burrell BE; Csencsits K; Lu G; Grabauskiene S; Bishop DK
    J Immunol; 2008 Sep; 181(6):3906-14. PubMed ID: 18768845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of low doses of IL-2 combined to rapamycin promotes allogeneic skin graft survival in mice.
    Pilon CB; Petillon S; Naserian S; Martin GH; Badoual C; Lang P; Azoulay D; Piaggio E; Grimbert P; Cohen JL
    Am J Transplant; 2014 Dec; 14(12):2874-82. PubMed ID: 25394722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.